Systematic review and meta-analysis explore late-stage outcomes in cancer screening, highlighting their link to mortality.
Exploratory analysis of the effect of the timing of the reporting of late-stage incidence on the association with the mortality outcome. The figure includes trials that reported their late-stage outcomes at least twice [at intervention phase (triangles), earlier than mortality (circles), and/or at mortality (squares)]. Each trial is then represented by two or up to three points connected by a straight line drawn at the main estimate of the screening effect on cancer-specific mortality; this line shows how the estimates of the screening effect on the late-stage incidence within a specific trial changed over time. Size of the points corresponds to precision of the mortality result (inverse variance of the estimate). Colors denote types of cancer (please see the legend).
No takes yet. Share an insight, caveat, or question.
Rebolj et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: